{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T09:47:55Z","timestamp":1785232075345,"version":"3.55.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007214","name":"Velux Stiftung","doi-asserted-by":"publisher","award":["1860"],"award-info":[{"award-number":["1860"]}],"id":[{"id":"10.13039\/100007214","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Timely diagnosis and therapeutic management of rare diseases (RDs) are greatly hampered by limited clinical information and a lack of reliable epidemiological data. RDs constitute a heterogeneous group of disorders, and although they have become major public health issues, there is a paucity of both population- and disease-based data on them, particularly in developing countries. Next-generation sequencing (NGS) has revolutionized the diagnosis of these disorders by allowing fast and cost-effective identification of disease-causing genetic variants, as well as the development of reliable, molecular diagnosis\u2013based registries. Presented here is a 20-year retrospective, single-center study of molecularly confirmed RDs, with causal variants classified as pathogenic or likely pathogenic according to the ACMG criteria. Only disorders with an OMIM disease number or publications regarding them were considered.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 605 RDs, classified in 14 different clinical categories, were genetically confirmed. The most common diseases were ocular disorders (34%), neurodevelopmental disorders (23.5%), and neurological disorders (11%). Among the 605 identified disorders, 326 were autosomal dominant, 225 were autosomal recessive, 43 were X-linked, 7 had mitochondrial inheritance, and 4 were caused by somatic mosaicism. A total of 534 genes\/genomic regions were demonstrated to carry disease-causing variants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      This is the first catalog of genetically confirmed RDs in Mexico, and it can be considered a first step toward a better characterization of the spectrum of such diseases in the country. Patients\u2019 increasing access to diagnostic exome and\/or genome sequencing tests has enabled unprecedented success in RD characterization at the genetic level. The vast majority of genetic diagnoses in our series (~\u200975%) occurred in the past eight years, which coincides with a wider availability of NGS testing in Mexico. Our catalog is freely accessible through an online database (\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/0198bb3b-526c-b682-3f6d-c5894015db9b.share.connect.posit.cloud\/\" ext-link-type=\"uri\">https:\/\/0198bb3b-526c-b682-3f6d-c5894015db9b.share.connect.posit.cloud\/<\/jats:ext-link>\n                      ), which is intended to be continuously maintained, extended, and updated with contributions from other health professionals in the field of RDs in Mexico. This resource might accelerate the characterization of such diseases in the country, and it may also play a role in the development of a reliable national registry of RD patients.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-026-04318-1","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T05:25:18Z","timestamp":1773984318000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The landscape of 605 genetically confirmed distinct rare diseases in a single center in Mexico (2005\u20132025)"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9716-8146","authenticated-orcid":false,"given":"Juan Carlos","family":"Zenteno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vianey","family":"Ordo\u00f1ez-Labastida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Montes-Almanza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Froylan","family":"Garcia-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Martinez-Herrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Carre\u00f1o-Bola\u00f1os","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocio","family":"Arce-Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar F.","family":"Chac\u00f3n-Camacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,20]]},"reference":[{"issue":"10479","key":"4318_CR1","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/S0140-6736(25)00211-9","volume":"405","author":"KM Boycott","year":"2025","unstructured":"Boycott KM, Giugliani R. Commissioners of the RDI\u2013Lancet Commission on Rare Diseases. The RDI-Lancet Commission on Rare Diseases: improving visibility to address health-care disparities for 400 million people. Lancet. 2025;405(10479):605\u20137.","journal-title":"Lancet"},{"issue":"4","key":"4318_CR2","first-page":"3","volume":"8","author":"A Fehr","year":"2023","unstructured":"Fehr A, Pr\u00fctz F. Rare diseases: a challenge for medicine and public health. J Health Monit. 2023;8(4):3\u20136.","journal-title":"J Health Monit"},{"issue":"5","key":"4318_CR3","doi-asserted-by":"publisher","first-page":"101123","DOI":"10.1016\/j.isci.2020.101123","volume":"23","author":"CE Lee","year":"2020","unstructured":"Lee CE, Singleton KS, Wallin M, Faundez V. Rare genetic diseases: nature\u2019s experiments on human development. iScience. 2020;23(5):101123.","journal-title":"iScience"},{"issue":"10","key":"4318_CR4","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/nrg3555","volume":"14","author":"KM Boycott","year":"2013","unstructured":"Boycott KM, Vanstone MR, Bulman DE, MacKenzie AE. Rare-disease genetics in the era of next-generation sequencing: discovery to translation. Nat Rev Genet. 2013;14(10):681\u201391.","journal-title":"Nat Rev Genet"},{"key":"4318_CR5","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1146\/annurev-genom-083115-022348","volume":"17","author":"NT Strande","year":"2016","unstructured":"Strande NT, Berg JS. Defining the clinical value of a genomic diagnosis in the era of next-generation sequencing. Annu Rev Genomics Hum Genet. 2016;17:303\u201332.","journal-title":"Annu Rev Genomics Hum Genet"},{"issue":"1","key":"4318_CR6","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.cell.2019.02.040","volume":"177","author":"KM Boycott","year":"2019","unstructured":"Boycott KM, Hartley T, Biesecker LG, Gibbs RA, Innes AM, Riess O, Belmont J, Dunwoodie SL, Jojic N, Lassmann T, et al. A diagnosis for all rare genetic diseases: the horizon and the next frontiers. Cell. 2019;177(1):32\u20137.","journal-title":"Cell"},{"key":"4318_CR7","doi-asserted-by":"crossref","unstructured":"Chung CCY, Hue SPY, Ng NYT, Doong PHL, Hong Kong Genome Project, Chu ATW, Chung BHY. Meta-analysis of the diagnostic and clinical utility of exome and genome sequencing in pediatric and adult patients with rare diseases across diverse populations. Genet Med. 2023;25(9):100896.","DOI":"10.1016\/j.gim.2023.100896"},{"issue":"21","key":"4318_CR8","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1056\/NEJMoa2314761","volume":"390","author":"MH Wojcik","year":"2024","unstructured":"Wojcik MH, Lemire G, Berger E, Zaki MS, Wissmann M, Win W, White SM, Weisburd B, Wieczorek D, Waddell LB, et al. N Engl J Med. 2024;390(21):1985\u201397.","journal-title":"N Engl J Med"},{"issue":"6","key":"4318_CR9","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1016\/j.gim.2022.03.005","volume":"24","author":"TA Lavelle","year":"2022","unstructured":"Lavelle TA, Feng X, Keisler M, Cohen JT, Neumann PJ, Prichard D, Schroeder BE, Salyakina D, Espinal PS, Weidner SB, Maron JL. Cost-effectiveness of exome and genome sequencing for children with rare and undiagnosed conditions. Genet Med. 2022;24(6):1349\u201361.","journal-title":"Genet Med"},{"issue":"10","key":"4318_CR10","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1016\/j.gim.2022.06.004","volume":"24","author":"BS Ferket","year":"2022","unstructured":"Ferket BS, Baldwin Z, Murali P, Pai A, Mittendorf KF, Russell HV, Chen F, Lynch FL, Lich KH, Hindorff LA, et al. Cost-effectiveness frameworks for comparing genome and exome sequencing versus conventional diagnostic pathways: a scoping review and recommended methods. Genet Med. 2022;24(10):2014\u201327.","journal-title":"Genet Med"},{"issue":"1","key":"4318_CR11","doi-asserted-by":"publisher","first-page":"6904","DOI":"10.1038\/s41598-023-33787-8","volume":"13","author":"H Runheim","year":"2023","unstructured":"Runheim H, Pettersson M, Hammarsj\u00f6 A, Nordgren A, Henriksson M, Lindstrand A, Levin L\u00c5, Soller MJ. The cost-effectiveness of whole genome sequencing in neurodevelopmental disorders. Sci Rep. 2023;13(1):6904.","journal-title":"Sci Rep"},{"issue":"4","key":"4318_CR12","doi-asserted-by":"publisher","first-page":"101069","DOI":"10.1016\/j.gim.2024.101069","volume":"26","author":"DA Regier","year":"2024","unstructured":"Regier DA, Loewen R, Chan B, Ehman M, Pollard S, Friedman JM, Stockler-Ipsiroglu S, van Karnebeek C, Race S, Elliott AM, et al. Real-world diagnostic outcomes and cost-effectiveness of genome-wide sequencing for developmental and seizure disorders: evidence from Canada. Genet Med. 2024;26(4):101069.","journal-title":"Genet Med"},{"key":"4318_CR13","unstructured":"www.orpha.http:\/\/www.net\/pdfs\/orphacom\/cahiers\/docs\/GB\/Rare_Disease_Registries.pdf"},{"issue":"1","key":"4318_CR14","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s13023-023-02719-0","volume":"18","author":"IC Hageman","year":"2023","unstructured":"Hageman IC, van Rooij IALM, de Blaauw I, Trajanovska M, King SK. A systematic overview of rare disease patient registries: challenges in design, quality management, and maintenance. Orphanet J Rare Dis. 2023;18(1):106.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"4318_CR15","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.jaci.2016.05.042","volume":"139","author":"A Stray-Pedersen","year":"2017","unstructured":"Stray-Pedersen A, Sorte HS, Samarakoon P, Gambin T, Chinn IK, Coban Akdemir ZH, Erichsen HC, Forbes LR, Gu S, Yuan B, et al. Primary immunodeficiency diseases: genomic approaches delineate heterogeneous Mendelian disorders. J Allergy Clin Immunol. 2017;139(1):232\u201345.","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"4318_CR16","doi-asserted-by":"publisher","first-page":"772","DOI":"10.34067\/KID.0001342020","volume":"1","author":"PC Wilson","year":"2020","unstructured":"Wilson PC, Love-Gregory L, Corliss M, McNulty S, Heusel JW, Gaut JP. Beyond panel-based testing: exome analysis increases sensitivity for diagnosis of genetic kidney disease. Kidney360. 2020;1(8):772\u201380.","journal-title":"Kidney360"},{"issue":"10","key":"4318_CR17","doi-asserted-by":"publisher","first-page":"5641","DOI":"10.3390\/ijms23105641","volume":"23","author":"V Palazzo","year":"2022","unstructured":"Palazzo V, Raglianti V, Landini S, Cirillo L, Errichiello C, Buti E, Artuso R, Tiberi L, Vergani D, Dirupo E, et al. Clinical and genetic characterization of patients with Bartter and Gitelman syndrome. Int J Mol Sci. 2022;23(10):5641.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"4318_CR18","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.ajhg.2024.05.006","volume":"111","author":"E Thorpe","year":"2024","unstructured":"Thorpe E, Williams T, Shaw C, Chekalin E, Ortega J, Robinson K, Button J, Jones MC, Campo MD, Basel D, et al. The impact of clinical genome sequencing in a global population with suspected rare genetic disease. Am J Hum Genet. 2024;111(7):1271\u201381.","journal-title":"Am J Hum Genet"},{"key":"4318_CR19","unstructured":"https:\/\/www.gob.mx\/salud\/articulos\/59561"},{"issue":"5","key":"4318_CR20","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, et al. ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405\u201324.","journal-title":"Genet Med"},{"issue":"7814","key":"4318_CR21","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41586-020-2434-2","volume":"583","author":"E Turro","year":"2020","unstructured":"Turro E, Astle WJ, Megy K, Gr\u00e4f S, Greene D, Shamardina O, Allen HL, Sanchis-Juan A, Frontini M, Thys C, et al. Whole-genome sequencing of patients with rare diseases in a national health system. Nature. 2020;583(7814):96\u2013102.","journal-title":"Nature"},{"issue":"20","key":"4318_CR22","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1056\/NEJMoa2035790","volume":"385","author":"D Smedley","year":"2021","unstructured":"Smedley D, Smith KR, Martin A, Thomas EA, McDonagh EM, Cipriani V, Ellingford JM, Arno G, Tucci A, Vandrovcova J, et al. 100,000 genomes pilot on rare-disease diagnosis in health care - preliminary report. N Engl J Med. 2021;385(20):1868\u201380.","journal-title":"N Engl J Med"},{"issue":"2","key":"4318_CR23","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/s41591-024-03420-w","volume":"31","author":"S Laurie","year":"2025","unstructured":"Laurie S, Steyaert W, de Boer E, Polavarapu K, Schuermans N, Sommer AK, Demidov G, Ellwanger K, Paramonov I, Thomas C, et al. Genomic reanalysis of a pan-European rare-disease resource yields new diagnoses. Nat Med. 2025;31(2):478\u201389.","journal-title":"Nat Med"},{"issue":"1","key":"4318_CR24","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41525-024-00455-3","volume":"10","author":"H Han","year":"2025","unstructured":"Han H, Seo GH, Hyun SI, Kwon K, Ryu SW, Khang R, Lee E, Kim J, Song Y, Jeong WC, et al. Exome sequencing of 18,994 ethnically diverse patients with suspected rare Mendelian disorders. NPJ Genom Med. 2025;10(1):6.","journal-title":"NPJ Genom Med"},{"issue":"2","key":"4318_CR25","first-page":"75","volume":"13","author":"M Stoyanova","year":"2025","unstructured":"Stoyanova M, Yahya D, Hachmeriyan M, Levkova M. Diagnostic yield of next-generation sequencing for rare pediatric genetic disorders: a single-center experience. Med Sci (Basel). 2025;13(2):75.","journal-title":"Med Sci (Basel)"},{"key":"4318_CR26","unstructured":"https:\/\/www.rarediseases.in\/rare-diseases\/, accessed March 25th 2024."},{"key":"4318_CR27","first-page":"100434","volume":"18","author":"D Wainstock","year":"2023","unstructured":"Wainstock D, Katz A. Advancing rare disease policy in Latin America: a call to action. Lancet Reg Health Am. 2023;18:100434.","journal-title":"Lancet Reg Health Am"},{"issue":"1","key":"4318_CR28","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/hpm.3712","volume":"39","author":"J Chen","year":"2024","unstructured":"Chen J, Li Y, Chang J. Rare diseases in developing countries: insights from China\u2019s collaborative network. Int J Health Plann Manage. 2024;39(1):135\u201340.","journal-title":"Int J Health Plann Manage"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-026-04318-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04318-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04318-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:32:14Z","timestamp":1781641934000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13023-026-04318-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,20]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4318"],"URL":"https:\/\/doi.org\/10.1186\/s13023-026-04318-1","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,20]]},"assertion":[{"value":"18 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the principles of the Declaration of Helsinki. The study was approved by the Ethics Committee of the Institute of Ophthalmology \u201cConde de Valenciana\u201d (CB-059-2021), with informed consent waived due to the retrospective and anonymized nature of the data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"170"}}